# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Isaac Newton (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN011-SYN-TD
- Date: 1693-09-28
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rupert Okonkwo-Fairbanks, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## What we are working on

- He has barely slept for two weeks, eats little, and feels he has lost his former steadiness of mind **S**
- He wrote angry letters to friends he now thinks he wronged, and wants to make amends **S**
- He asks whether the metals in his laboratory have poisoned him **S**

## Your goals

- Toxic and other medical causes assessed by the second visit. Target: 1693-10-08. Recorded outcome: Blood count, metabolic panel, TSH, vitamin B12, kidney tests, blood lead, and MoCA normal; blood and urine mercury raised from his work, below levels linked to overt toxicity. **S**
- No further exposure to mercury and other metals until the laboratory is made safe. Target: 1694-01-31. Recorded outcome: Laboratory closed since intake; urine mercury falling. **S**
- Response (PHQ-9 down by at least 50 percent) by eight to twelve weeks of treatment, then remission (PHQ-9 below 5). Target: 1693-12-31. Recorded outcome: PHQ-9 14 after three weeks of sertraline, 30 percent below baseline. **S**
- No suicidal thoughts and no thoughts of harming others. Target: 1693-12-31. Recorded outcome: None at any visit. **S**
- At least six hours of sleep most nights without hypnotics. Target: 1693-12-31. Recorded outcome: About five and a half hours by the third chronic-care visit. **S**

## What we agreed to do

- Workup for medical and toxic causes: blood count, metabolic panel, TSH, vitamin B12, MoCA, urine albumin-to-creatinine ratio and dipstick protein, blood mercury, 24-hour urine mercury with creatinine, and blood lead; examination for tremor, gingivitis, stomatitis, and neuropathy; no provoked (chelator-challenge) urine test and no broad metal screen. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); Evaluating Mercury Exposure: Information for Health Care Providers (2018); NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026); American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010); Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013) **S**
- Removal from exposure now: stop all heating of metals, close the laboratory, and do not sleep in the adjoining rooms until they are checked; the university environmental health and safety office to measure mercury vapor, decontaminate, and remove the mercury and arsenic compounds. Guideline: Evaluating Mercury Exposure: Information for Health Care Providers (2018); NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026); American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010); Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013) **S**
- Suicide and violence risk assessment with a safety plan: warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; toxic chemicals out of reach; safety reviewed at every visit. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Occupational and environmental medicine (medical toxicology) consultation on the meaning of the mercury results, chelation, the workplace hazard assessment, and a safe return to laboratory work. Guideline: Evaluating Mercury Exposure: Information for Health Care Providers (2018); NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026); American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010); Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013) **S**
- Sleep: cognitive behavioral therapy for insomnia (a fixed rising time, a sleep window, out of bed after 20 minutes awake, no dozing in the evening chair, no night work); no hypnotics or sedating antihistamines. Guideline: Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016) **S**
- Shared decision on depression treatment: sertraline 50 mg each morning with weekly cognitive behavioral therapy; PHQ-9 at every visit; an increase if the response is under 50 percent after six to eight weeks; continue for at least six to twelve months after remission. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) (2022) **S**
- Collaborative care: the clinic's psychiatrist reviews his PHQ-9, safety, and medicine each week with the care manager, and sees him in person if psychotic features, suicidal thoughts, or thoughts of harming others appear, or if he does not respond. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022) **S**
- Exposure follow-up: repeat 24-hour urine mercury and blood mercury four to six weeks after removal and again at three months; creatinine and urine albumin-to-creatinine ratio at three months; return to laboratory work only with a fume hood, a mercury spill kit, no food at the bench, and urine mercury below the biological exposure index. Guideline: Evaluating Mercury Exposure: Information for Health Care Providers (2018); NIOSH Pocket Guide to Chemical Hazards: Mercury compounds [except (organo) alkyls] (as Hg) (2026); American College of Medical Toxicology Position Statement on Post-Chelator Challenge Urinary Metal Testing (2010); Use and Misuse of Metal Chelation Therapy (McKay CA, editorial) and Recommendations for Provoked Challenge Urine Testing (Ruha AM), proceedings of the ACMT symposium (2013) **S**
- Nutrition: three regular meals a day, weight at every visit. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022) **S**

## Follow-up

- 1693-09-28: Primary care visit for a year of poor sleep and appetite, two weeks of near-sleeplessness, and suspicious thoughts about friends, in a researcher who heats mercury and other metals **S**
- 1693-10-08: Ten-day review of metal and laboratory results, diagnosis, start of treatment, and occupational and environmental medicine consultation **S**
- 1693-10-22: Preventive health visit at 50 **S**
- 1693-10-29: Three-week depression and exposure follow-up with a repeat 24-hour urine mercury **S**

This teaching document does not replace care from a qualified clinician.
